Dermagnostix
Frank Schwemmer is currently working as an Experte R&D at Dermagnostix since October 2023. Prior to this role, Frank served as the Chief Scientific Officer & Co-Founder at SpinDiag GmbH from March 2016 to October 2023. Frank also worked as a Postdoctoral Researcher at Hahn-Schickard from January 2016 to June 2018. Frank completed their Doctor of Philosophy (Ph.D.) in Engineering at The University of Freiburg from 2010 to 2015 and holds a Master’s Degree in Physics from The University of Texas at Austin from 2009 to 2010.
This person is not in any teams
Dermagnostix
At Dermagnostix, we develop groundbreaking diagnostics for dermatology to advance clinical practice and improve patients’ lives. Why dermatology? • One third of the population suffers from at least one skin condition – with a strong upward trend. • Skin diseases impair patients’ quality of life more drastically than cancer and diabetes. • Biologicals and small-molecule inhibitors have created an unprecedented potential for precision medicine. Diagnostics is lagging behind. Our solution? Groundbreaking translational research meets cutting-edge technology: Dermagnostix provides unique diagnostic tests for unmet clinical needs in dermatology on a fully automated portable laboratory. With PsorX, Dermagnostix launches the first in-class molecular test for differential diagnosis of psoriasis and eczema. Get diagnostic support for hard-to-tackle skin diseases using our simple and fast system: Sample in – Answer out. www.dermagnostix.com